04.20.18
Karthikeyan (Karthik) Kumar has been appointed business development manager, InClinica. Mr. Kumar will be based at the company’s office in Kuala Lumpur, Malaysia.
In his new role, Mr. Kumar will be responsible for supporting clinical research organization sales and business development activities, generating leads, and providing customer relationship management and clinical operations management support.
“Karthik will make an excellent addition to the InClinica team in Malaysia,” said James Nolan, chief executive officer at InClinica. “His business experience coupled with strong clinical operations knowledge will contribute to the expansion of our business and help build the company’s presence in Asia’s booming clinical arena.”
Mr. Kumar has more than 12 years of experience in pharmaceuticals and clinical research. He joins the company from Siro Clinipharm, where he served as assistant manager responsible for managing all operations in Malaysia and Singapore. He spent ten years with the company, and his work has ranged from Phase I to IV mult-centric studies, pilot and in-house studies. Mr. Kumar also served in roles at Natural Remedies and ClinWorld.
In his new role, Mr. Kumar will be responsible for supporting clinical research organization sales and business development activities, generating leads, and providing customer relationship management and clinical operations management support.
“Karthik will make an excellent addition to the InClinica team in Malaysia,” said James Nolan, chief executive officer at InClinica. “His business experience coupled with strong clinical operations knowledge will contribute to the expansion of our business and help build the company’s presence in Asia’s booming clinical arena.”
Mr. Kumar has more than 12 years of experience in pharmaceuticals and clinical research. He joins the company from Siro Clinipharm, where he served as assistant manager responsible for managing all operations in Malaysia and Singapore. He spent ten years with the company, and his work has ranged from Phase I to IV mult-centric studies, pilot and in-house studies. Mr. Kumar also served in roles at Natural Remedies and ClinWorld.